Related Experiment Video
Updated: Jun 3, 2026

08:05
Design and Analysis for Fall Detection System Simplification
Published on: April 6, 2020
A machine learning approach to quantifying fall conversion risk in fall-naïve Parkinson's patients.
A Elizabeth Jansen1, Paul Cantlay1, Christina Felix2
1Cleveland Clinic, Department of Biomedical Engineering, 9500 Euclid Ave., Cleveland, OH, USA.
Parkinsonism & Related Disorders
|June 1, 2026
Summary
Machine learning models can now predict Parkinson's disease (PD) fall risk. This helps identify people with Parkinson's disease (PwPD) at risk of recurrent falls, potentially improving quality of life.
Area of Science:
- Neurology
- Biomedical Engineering
- Data Science
Background:
- Recurrent falls significantly impact quality of life and increase healthcare costs for people with Parkinson's disease (PwPD).
- Existing fall prediction models struggle to identify individuals with Parkinson's disease (PD) who will transition from non-fallers to recurrent fallers.
- There is a critical need for improved methods to predict fall risk in PwPD.
Purpose of the Study:
- To develop and validate a machine learning model for predicting fall risk in people with Parkinson's disease (PwPD).
- To identify key factors contributing to the transition from non-faller to recurrent faller status in PwPD.
Main Methods:
- Utilized baseline clinical motor, biomechanical, cognitive, and quality of life data from 246 PwPD in a clinical trial.
- Developed a fall conversion prediction model using an XGBoost algorithm on data from 174 fall-naïve participants.
- Employed repeated cross-validation to assess model performance, with Area Under the Curve (AUC) as the primary metric.
Main Results:
- The XGBoost model achieved a mean cross-validated AUC of 0.63.
- The model demonstrated a mean sensitivity of 66% and specificity of 51%, with higher sensitivity (77%) for predicting multiple falls.
- Key predictive features included biomechanical balance assessments, NeuroQoL and MDS-UPDRS questionnaires, and cognitive tests (Trails Making Test A, Symbol Digit Matching Test).
Conclusions:
- Multifaceted data, including biomechanical and self-report measures, are valuable for identifying PwPD at risk of initial and recurrent falls.
- Enhanced precision in predicting falls can inform targeted interventions and behavioral modifications to prevent the progression to recurrent faller status.
- This approach holds potential for improving management strategies and mitigating the impact of falls in people with Parkinson's disease (PD).
Related Concept Videos
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

